Portfolio News

Embotics to Expand its Cloud Management Software Market Share: Signs Channel Partnership Agreement with Gotham Technology Group to Penetrate Mid-to-Large Enterprises

January 15, 2014
OTTAWA, ONTARIO - Embotics®, one of the world’s leading providers of enterprise‐class Cloud Management Software, today announced that it has signed a channel partnership agreement with Gotham Technology Group, one of the founding members of M7 Global Partners. The agreement is part of a worldwide channel strategy implemented by Embotics to ensure comprehensive global coverage of its award‐winning vCommander™ Cloud Management Software.
The strategic alliance with Gotham Technology Group will continue to increase Embotics’ North American

Interface Biologics and Q3 Medical Devices Sign Agreement to Develop Next Generation Drug Coated Balloon with Kinesyx Technology

January 14, 2014
TORONTO, ONTARIO - Interface Biologics Inc. (IBI), and Q3 Medical Devices Limited are pleased to announce the signing of a joint development and commercialization agreement to combine IBI's Kinesyx bioactive oligomers with the balloon technology of Q3 Medical Devices wholly owned subsidiary, Qualimed Innovative Medizinprodukte GmbH, to create a next generation drug coated balloon for both coronary and peripheral applications.

WireIE Meets Highest Global Standards for Carrier Ethernet Services

November 19, 2013
TORONTO, ON - WireIE, a leader in delivering Carrier Ethernet Services to rural, remote and hard‐to‐reach locations, announces today that it has earned the industry's highest level of certification for the design and delivery of Carrier Ethernet networks. The Metro Ethernet Forum (MEF), the international defining body for Carrier Ethernet, issues the MEF CE 2.0 certification to organizations that pass rigorous testing processes.

The University of the West Indies Selects Resolver to Support Governance, Risk and Compliance Program

November 19, 2013

Toronto, ON - Resolver is pleased to announce that The University of the West Indies (The UWI) has selected and implemented Resolver’s Governance, Risk and Compliance solution – GRC Cloud – to support its audit, enterprise risk management and other GRC functions.

Resolver and Advantage announce Strategic Partnership streamlining GRC for Canada’s Energy Sector

January 7, 2014

Toronto, ON - Resolver Inc., a leading provider of Governance, Risk and Compliance (GRC) software and Advantage Professional Services Inc., a provider of GRC, HR and recruitment advisory services, today announced a strategic partnership to arm the energy sector of Canada with GRC capabilities needed to drive high performance and maximize revenue potential.

Premier Selects AngioDynamics’ BioFlo PICC as a Breakthrough Technology

June 12, 2013

Albany, NY - AngioDynamics (ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that its BioFlo peripherally inserted central catheter (PICC) was one of 14 medical innovations on display in front of thousands of healthcare providers and experts at the Premier healthcare alliance’s 2013 Breakthroughs Conference and Exhibition.

Fusebill Announces $2M Investment Led by OMERS Ventures with Covington Capital

April 16, 2013

KANATA, ONTARIO -- Fusebill, a leading provider of automated, flexible and affordable subscription billing and payment solutions, is announcing a $2 million investment led by OMERS Ventures, the venture capital investment arm of OMERS, one of Canada's largest pension plans. Covington Capital Corp., one of Canada's largest providers of venture capital investment funds, also participated in the investment.

BPS Resolver Wins International Software Award

February 1, 2013

TORONTO, CANADA – January 30, 2013 – BPS Resolver is pleased to announce that it has been awarded the title of Best Issue and Investigations Management Provider by European CEO Magazine.

Interface Biologics' CSO Paul Santerre receives NSERC Synergy Innovation Award from Governor General

March 5, 2013

TORONTO, ONTARIO--March 5, 2013 - Interface Biologics Inc. (IBI), a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that Dr.

EGI Financial Book Value Per Share Increases by 9%, Announces Share Buyback Target

February 25, 2013

Toronto, ON - February 25, 2013 - EGI Financial Holdings Inc. ("EGI" or "the Company") (TSX: EFH), which operates in the property and casualty insurance industry in Canada, the United States and Europe, today reported net income of $4.5 million, or $0.38 per diluted share, for the three months ended December 31, 2012. This compares to $3.3 million, or $0.29 per diluted share, up 31% from the same period in 2011.